Chinese regulators are investigating Meta’s $2 billion acquisition of AI startup Manus to ensure compliance with export control laws. The deal enhances Meta’s AI capabilities and provides immediate revenue potential through subscription services.
Lawmakers are introducing bipartisan legislation in the U.S. Senate and House to regulate AI use in employment, focusing on transparency and human oversight. Employers must navigate potentially conflicting federal and state regulations to ensure compliance.
BioPharma Consulting Group has launched a new digital transformation advisory framework to help life sciences organizations meet increasing regulatory expectations around artificial intelligence and data integrity, bridging the compliance gap as companies adopt AI-driven tools and cloud-based Quality Management Systems.
The Australian Human Rights Commission proposes an ethical framework for AI development and use in Australia, emphasizing human rights, accountability, and calls for a moratorium on harmful facial recognition technology. The Discussion Paper also ensures individuals can understand and challenge AI-driven decisions affecting them.
Utah has launched a pilot program allowing patients with chronic health conditions to refill prescriptions via an AI platform, making it the first state to test such technology. This initiative aims to improve medication adherence and reduce healthcare costs while ensuring human judgment remains central to medical decision-making.
Senate Democrats are intensifying efforts to block President Trump’s executive order that restricts states’ authority to regulate artificial intelligence. The new States’ Right to Regulate AI Act aims to protect state rights and counter federal overreach.
